+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

UK Animal Vaccine Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited
  • ID: 4969073
UK Animal Vaccine Market Size, Share & Trends Analysis Report, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) and Forecast, 2019-2025.

UK animal vaccine market is estimated to grow at a CAGR of around 6.1% during the forecast period. Owing to the growing demand for chicken, the farmers in the UK has been increasing the production every year. With the increasing chicken production, the prevalence of diseases among chickens is also growing in the country. Poultry animals are facing serious infections, such as septicemia, gastroenteritis, respiratory diseases, and mycoplasma infections. Therefore, poultry vaccines are being significantly used for the prevention and controlling of contagious poultry diseases. There is a significant awareness regarding poultry science among farmers, which in turn, is further encouraging the growth of the market.

Additionally, farmers are replacing antibiotics with timely vaccination for poultry farming. The adverse effect of antibiotics on chick's health and environmental concerns is driving the replacement. Therefore, with the growing rate of replacement, farmers are increasing the use of regular vaccinations for the poultry animals in order to maximize the production of healthy poultry food. Intensive broiler rearing is associated with the growing replacement of antibiotics with vaccination.

Some crucial players in the UK animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Anomalcare Group PLC and Bayer AG. In order to survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in February 2019, MSD Animal Health, a division of Merck & Co., Inc. declared the introduction of their new triple action pig vaccine to control erysipelas, porcine parvovirus and leptospirosis, offering up to 12 months immunity. The first of its kind vaccine, PORCILIS Ery+Parvo+Lepto offers protection against three of the major diseases that cause reproductive failures in pigs.

Research Methodology

The market study of the UK animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation
  • UK Animal Vaccine Market Research and Analysis, By Type
  • UK Animal Vaccine Market Research and Analysis, By Technology

The Report Covers
  • Comprehensive research methodology of the UK animal vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK animal vaccine market.
  • Insights about market determinants which are stimulating the UK animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. UK Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. UK Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Company Profiles
6.1. Animalcare Group plc
6.2. Bayer AG
6.3. Bimeda, Inc.
6.4. Ceva Santé Animale
6.5. ECO Animal Health
6.6. Elanco
6.7. Merck & Co., Inc.
6.8. Vetoquinol S.A.
6.9. Virbac SA
6.10. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Animalcare Group plc
  • Bayer AG
  • Bimeda, Inc.
  • Ceva Santé Animale
  • ECO Animal Health
  • Elanco
  • Merck & Co., Inc.
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis, Inc.